Rostock International Parkinson’s Disease Study: an International, Multicenter, Epidemiological Observational Study
Sponsor:
Brief Summary:
epidemiological observational study aiming at identification of 1,500 LRRK2-positive
patients, the identification of 1,500 non-LRRK2 PD patients and the establishment of a
candidate biomarker in the LRRK2-positive cohort.
Criteria
– Informed consent is obtained from the participant.
– The participant is equal to or older than 18 years old.
– The participant is clinically diagnosed with Parkinson’s disease
– The participant is a family member of a participant with LRRK2 parkinsonism.
– The participant is a member of a high risk population.
Exclusion Criteria:
– Inability to provide informed consent.
– The participant is younger than 18 years old.
– The participant is not suffering from Parkinson’s disease.
– The participant is not a family member of a participant with LRRK2 parkinsonism.
– The participant is not a member of a high risk population.
– Previously enrolled in the study.
– Participant in custody.
Locations
- Pharmacology Research Institute, Encino, California, United States, 91316
- Neuro-Pain Medical Center, Fresno, California, United States, 93710
- University of California (UC) San Diego, La Jolla, California, United States, 92093
- Pharmacology Research Institute, Los Alamitos, California, United States, 90720
- Pharmacology Research Institute, Newport Beach, California, United States, 92660
